[Diagnosis, histopathologic grading and prognostic moleculer marker analysis in patients with pancreatic neuroendocrine neoplasm].
E-mail: guoping.cai@yale.edu.
Fang
F
Bao
Guo-rong
GR
Chen
Pei
P
Hui
Guo-ping
GP
Cai
D006801:Humans; D064799:Hypoxia-Inducible Factor-Proline Dioxygenases / Q000378:metabolism; D019394:Ki-67 Antigen / Q000378:metabolism*; D035683:MicroRNAs / Q000378:metabolism; D060787:Neoplasm Grading; D009367:Neoplasm Staging; D015260:Neprilysin / Q000378:metabolism; D018358:Neuroendocrine Tumors / Q000145:classification / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D000072636:PAX8 Transcription Factor; D051761:Paired Box Transcription Factors / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000145:classification / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D011379:Prognosis; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins / Q000378:metabolism
D019394:Ki-67 Antigen; D035683:MicroRNAs; D000072636:PAX8 Transcription Factor; C083325:PAX8 protein, human; D051761:Paired Box Transcription Factors; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins; C490190:EGLN1 protein, human; D064799:Hypoxia-Inducible Factor-Proline Dioxygenases; D015260:Neprilysin